Ovid Therapeutics Inc. Financial Ratios — OVID Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-36.33	-90.97	-75.82	-94.11	-103.38	90.83	-30.97	-34.98	-22.38	-14.33
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	110.02	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	-642.97	59.72	-3,604.47	-14,977.81	-10,825.44	-581.44
Operating Margin (%)	- -	- -	- -	- -	- -	-645.4	59.61	-3,696.4	-15,122.7	-10,933.75	-585.2
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	105.04	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-642.26	59.58	-3,604.66	-13,351.79	-4,670.14	-240.13
Profit Margin (%)	- -	- -	- -	- -	- -	-642.26	58.95	-3,604.66	-13,351.79	-4,670.14	-240.13
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-642.26	58.95	-3,604.66	-13,351.79	-4,670.14	-240.13
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	1.07	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	17	16	15	13
ST Debt	- -	- -	- -	- -	- -	- -	- -	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	16	15	13	12
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.31	-0.27	-0.24	-0.32
Net Debt/EBITDA	5.31	2.31	1.34	0.69	0.69	0.89	-1.51	0.83	0.46	0.43	0.31
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.3	-0.27	-0.24	-0.32
Net Debt/EBIT	5.3	2.3	1.34	0.69	0.68	0.88	-1.51	0.81	0.46	0.42	0.31
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-19.16	-67.7	-112.56	-320.4	-263.6	-387.39	-88.05	-145.21	-192.88	-330.08	-213.06
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	12.1	16.81	19.67	9.17
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-7.66	-5.64	-4.64	-3.89
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	10.31	10.25	14.56	7.94
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	12.5	18.23	21.63	10.27
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-7.91	-6.11	-5.1	-4.35
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	10.65	11.11	16.01	8.89
Net Debt to Equity	-102.76	-105.37	-104.42	-94.03	-59.83	-165.1	-104.48	-33.92	-30.8	-38.55	-10.07
Net Debt/Capital (%)	83.84	59.14	46.39	19.29	16.43	19.67	52.3	17.68	9.36	8.33	4.09
EBITDA	-13	-22	-65	-53	-61	-81	124	-54	-59	-61	-42
EBITDA-CapEx	-13	-23	-65	-53	-61	-82	124	-56	-59	-61	-42
Operating Income (Loss)	-13	-23	-65	-53	-61	-81	124	-56	-59	-62	-42

Liquidity (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	30.29	13.91	14.47	4.69	7.29	3.26	12.69	18.45	9.22	5.04	8.4
Current Ratio	30.44	14.04	14.71	5.01	7.58	3.39	12.87	18.79	9.55	5.32	8.97
Quick Ratio	30.32	13.91	14.47	4.76	7.39	3.27	12.69	18.45	9.22	5.04	8.4
CFO/Avg Current Liab	- -	-5.89	-6.45	-6.13	-5.27	-3.17	6.44	-5.07	-4.96	-5.09	-4.08
Common Equity/Total Assets	-19.16	-67.7	-112.56	-320.4	-263.6	-387.39	-88.05	-145.21	-192.88	-330.08	-213.06
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	12.1	16.81	19.67	9.17
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-7.66	-5.64	-4.64	-3.89
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	10.31	10.25	14.56	7.94
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	12.5	18.23	21.63	10.27
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-7.91	-6.11	-5.1	-4.35
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	10.65	11.11	16.01	8.89
CFO/Total Liabilities	-237.55	-476.83	-522.66	-515.11	-472.18	-159.73	801.52	-240.19	-81.42	-233.72	-189.08
CFO/CapEx	-97.38	-94.2	-664.1	-129.42	-209.35	-132.04	626.22	-38.93	-1,144.53	-788.11	- -
Altman's Z-Score	0.27	-1.25	16.16	-3.28	3.83	-5.49	11.81	1.17	-0.82	-4.58	0.22

Working Capital (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	191	60	163	135	217	131	227	66	120
- Cash & Cash Equivalents	70	52	87	36	42	72	188	45	27	26	13
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	17	16	15	13
Enterprise Value	-70	-52	104	18	86	63	29	19	137	28	64
Total Capital	-13	-36	-101	-153	-213	-294	-171	-209	-262	-289	-308
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-7.91	-6.11	-5.1	-4.35
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.89	0.12	0.53	0.21
EV/Sales	- -	- -	- -	- -	- -	4.99	0.14	12.33	350.61	49.27	8.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	0.23	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	0.23	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	0.24	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	0.24	- -	- -	- -	- -
Diluted Market Cap	- -	- -	191	60	163	135	218	131	227	66	120
Diluted Enterprise Value	-70	-52	104	23	121	63	31	103	216	55	120
EV per Share	- -	- -	5.37	0.74	2.19	1.08	0.43	0.26	1.95	0.39	0.87
TTM Sales	- -	- -	- -	- -	- -	13	208	2	- -	1	7
TTM EBITDA	-13	-22	-65	-53	-61	-81	124	-54	-59	-61	-42
TTM Operating Income	-13	-23	-65	-53	-61	-81	124	-56	-59	-62	-42
TTM Cash Flow to Firm	-5	-18	-31	-46	-51	-52	119	-55	-46	-56	-38
TTM Free Cash Flow to Firm	-5	-18	-31	-45	-51	-51	119	-54	-46	-56	-38

Multiples (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.08	-1.32	-3.2	-2.64	1.84	-2.43	-4.97	-1.18	-3.14
EV/EBIT	- -	- -	- -	- -	- -	- -	0.23	- -	- -	- -	- -
Enterprise Value	-70	-52	104	18	86	63	29	19	137	28	64
Low Price	- -	- -	5.28	2.42	1.53	1.8	2.27	1.41	1.8	0.68	0.24
EV/Sales	- -	- -	- -	- -	- -	4.99	0.14	12.33	350.61	49.27	8.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	0.23	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	1.76	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-2.92	-3.41	-1.58	-3.51	1.97	-3.04	-4.31	-5.51	-3.55
Price/Earnings High	- -	- -	-4.76	-5.43	-3.4	-6.78	2.64	-4.62	-5.58	-11	-8.51
Price/Earnings Low	- -	- -	-1.58	-1.15	-0.99	-1.3	1.25	-1.83	-2.43	-1.82	-1.03
Price/Book Value	- -	- -	-1.9	-0.39	-0.76	-0.46	-1.26	-0.58	-0.82	-0.22	-0.37
Price/Book Value Average	- -	- -	-1.88	-1.16	-0.45	-0.97	-1.41	-0.73	-0.81	-0.48	-0.19
Price/Book Value High	- -	- -	-3.06	-1.85	-0.96	-1.87	-1.89	-1.11	-1.05	-0.96	-0.46
Price/Book Value Low	- -	- -	-1.01	-0.39	-0.28	-0.36	-0.89	-0.44	-0.46	-0.16	-0.06
Price/Tangible Book Value	- -	- -	2.29	1.55	2.34	3.12	1.21	0.99	2.59	0.97	0.92
Price/Tangible Book Value Average	- -	- -	2.27	4.62	1.37	6.56	1.35	1.25	2.58	2.14	0.47
Price/Tangible Book Value High	- -	- -	3.7	7.34	2.95	12.69	1.8	1.89	3.34	4.26	1.13
Price/Tangible Book Value Low	- -	- -	1.23	1.55	0.86	2.43	0.85	0.75	1.45	0.71	0.14
Price/Sales	- -	- -	- -	- -	- -	10.7	1.04	87.17	579.77	116.97	16.57
Price/Sales Average	- -	- -	- -	- -	- -	22.53	1.16	109.43	575.63	257.46	8.53
Price/Sales High	- -	- -	- -	- -	- -	43.55	1.55	166.37	745.42	513.63	20.44
Price/Sales Low	- -	- -	- -	- -	- -	8.34	0.74	66.08	324.09	85.19	2.47
Price/Cash Flow	- -	- -	-6.07	-1.31	-3.19	-2.62	1.83	-2.37	-4.96	-1.18	-3.14
Price/Cash Flow Average	- -	- -	-6.02	-3.89	-1.87	-5.51	2.04	-2.98	-4.93	-2.6	-1.61
Price/Cash Flow High	- -	- -	-9.79	-6.19	-4.02	-10.65	2.73	-4.53	-6.38	-5.2	-3.87
Price/Cash Flow Low	- -	- -	-3.25	-1.31	-1.17	-2.04	1.29	-1.8	-2.78	-0.86	-0.47
Price/Free Cash Flow Average	- -	- -	-6.03	-3.92	-1.87	-5.55	2.06	-3.06	-4.93	-2.61	-1.61
Price/Free Cash Flow High	- -	- -	-9.81	-6.24	-4.04	-10.73	2.75	-4.65	-6.39	-5.2	-3.87
Price/Free Cash Flow Low	- -	- -	-3.25	-1.32	-1.18	-2.06	1.3	-1.85	-2.78	-0.86	-0.47
EV/Sales Average	- -	- -	- -	- -	- -	16.82	0.26	90.57	547.46	237.06	8.56
EV/Sales High	- -	- -	- -	- -	- -	37.84	0.65	147.51	717.25	493.23	20.47
EV/Sales Low	- -	- -	- -	- -	- -	2.63	- -	47.22	295.93	64.79	2.5
EV/EBITDA Average	5.31	2.31	-1.58	-2.67	-0.87	-2.62	0.44	-2.51	-3.66	-2.19	-1.47
EV/EBITDA High	5.31	2.31	-3.4	-4.65	-2.68	-5.88	1.09	-4.09	-4.79	-4.56	-3.52
EV/EBITDA Low	5.31	2.31	-0.23	-0.44	-0.3	-0.41	-0.28	-1.31	-1.98	-0.6	-0.43
EV/EBIT Average	5.3	2.3	-1.57	-2.66	-0.87	-2.61	0.44	-2.45	-3.62	-2.17	-1.46
EV/EBIT High	5.3	2.3	-3.4	-4.64	-2.66	-5.86	1.1	-3.99	-4.74	-4.51	-3.5
EV/EBIT Low	5.3	2.3	-0.23	-0.44	-0.29	-0.41	-0.28	-1.28	-1.96	-0.59	-0.43
Last Price	- -	- -	9.87	2.42	4.15	2.31	3.21	1.86	3.22	0.93	1.63
High Price	- -	- -	15.93	11.45	5.24	9.4	4.8	3.55	4.14	4.1	2.01
Enterprise Value Average	-70	-52	102	141	53	212	54	136	215	134	62
Enterprise Value High	-70	-52	221	246	164	477	136	222	281	279	148
Enterprise Value Low	-70	-52	15	23	18	33	-35	71	116	37	18

Shares Outstanding	25	25	25	25	55	66	70	70	71	71	130
Diluted Weighted Avg Shares	20	20	19	25	39	58	68	70	71	71	74
Basic Weighted Avg Shares	20	20	19	25	39	58	67	70	71	71	74
Revenue per Share	- -	- -	- -	- -	- -	0.22	3.09	0.02	0.01	0.01	0.1
EBITDA per Share	-0.67	-1.15	-3.36	-2.14	-1.56	-1.39	1.84	-0.77	-0.83	-0.86	-0.57
Operating Income per Share	-0.67	-1.15	-3.36	-2.15	-1.57	-1.39	1.84	-0.79	-0.84	-0.87	-0.58
Basic EPS, GAAP	-0.67	-1.14	-3.35	-2.11	-1.54	-1.39	1.82	-0.77	-0.74	-0.37	-0.24
Basic EPS from Cont Ops	-0.67	-1.14	-3.35	-2.11	-1.54	-1.39	1.82	-0.77	-0.74	-0.37	-0.24
Diluted EPS, GAAP	-0.67	-1.14	-3.35	-2.11	-1.54	-1.39	1.8	-0.77	-0.74	-0.37	-0.24
Diluted EPS from Cont Ops	-0.67	-1.14	-3.35	-2.11	-1.54	-1.39	1.8	-0.77	-0.74	-0.37	-0.24
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.28	-0.91	-1.63	-1.85	-1.3	-0.88	1.76	-0.78	-0.65	-0.79	-0.52
Free Cash Flow per Basic Share	-0.28	-0.92	-1.63	-1.86	-1.31	-0.89	1.75	-0.8	-0.65	-0.79	-0.52
Cash & Equivalents per Share	3.57	2.65	4.5	1.68	1.96	1.23	2.78	1.83	1.5	0.75	0.94
Book Value per Share	-0.69	-1.83	-5.21	-6.2	-5.43	-5.03	-2.54	-3.2	-3.94	-4.29	-4.36
Tangible Book Value per Share	3.47	2.51	4.31	1.56	1.77	0.74	2.66	1.88	1.24	0.96	1.77

Ovid Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)